Group 1 - The food processing sector increased by 0.66% on September 11, with Jiyuan Group leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] - Key stocks in the food processing sector showed various performance, with Jiyuan Group closing at 32.99, up 3.32%, and *ST Chuntian at 4.90, up 2.51% [1] Group 2 - The food processing sector experienced a net outflow of 35.10 million yuan from institutional funds, while retail investors saw a net inflow of 62.52 million yuan [2] - Major stocks like Jiyuan Group and Guangming Meat Industry had significant net inflows from institutional and retail investors, indicating varied investor sentiment [3] - The overall trading volume and turnover in the food processing sector reflected active market participation, with notable transactions in stocks like Jiyuan Group and Jinzi Ham [1][2]

Core Insights - The company reported a revenue of 563 million yuan for the first half of 2025, representing a year-on-year increase of 15.65%, and a net profit attributable to shareholders of 98 million yuan, up 3.99% year-on-year [1] - In Q2 2025, the company achieved a revenue of 298 million yuan, a year-on-year increase of 14.83%, with a net profit attributable to shareholders of 55 million yuan, reflecting a slight increase of 0.26% year-on-year [1] Business Segments - **HMB**: In H1 2025, HMB sales reached 158 million yuan, a year-on-year increase of 3.75%. The company is expanding its market presence by launching differentiated adult milk powder products and new products targeting GLP-1 users [2] - **Glucosamine & Chondroitin Sulfate**: H1 2025 sales for glucosamine were 106 million yuan, up 9.82%, while chondroitin sulfate sales surged to 80 million yuan, a significant increase of 106.44%, primarily due to strong sales from major client Nutramax [2] - **Formulation Products**: H1 2025 tablet sales reached 119 million yuan, a year-on-year increase of 23.01%, driven by substantial sales growth in key markets [3] Financial Metrics - The company's gross margin and net profit margin for H1 2025 were 43.69% and 17.35%, respectively, showing a slight decline of 1.38 and 1.95 percentage points year-on-year, attributed to changes in product mix [4] - The company’s expense ratios for sales, management, finance, and R&D were 7.19%, 12.55%, -1.92%, and 4.33%, respectively, with notable increases in sales and management expense ratios [4] Strategic Initiatives - The company is focusing on enhancing its core competencies through the "One TSI" strategic organizational transformation and digitalization efforts, which are progressing as planned [5] - The company has developed an "Optimized Raw Material Technology Innovation Platform" to enhance product customization and differentiation, with new products targeting mid-to-high-end market segments [5] Profit Forecast - The company forecasts revenues of 1.184 billion yuan, 1.436 billion yuan, and 1.758 billion yuan for 2025-2027, with year-on-year growth rates of 18.2%, 21.2%, and 22.5%, respectively [5]

Financial Performance - The company reported a total revenue of 563 million yuan for the first half of 2025, representing a year-on-year increase of 15.65% [1] - The net profit attributable to shareholders reached 97.71 million yuan, up 3.99% year-on-year [1] - In Q2 2025, total revenue was 298 million yuan, showing a year-on-year growth of 14.83%, while net profit for the same period was 55.11 million yuan, a slight increase of 0.26% [1] Key Financial Ratios - The gross margin for the period was 43.69%, down 3.07% compared to the previous year, while the net margin decreased by 10.03% to 17.44% [1] - Total selling, administrative, and financial expenses amounted to 100 million yuan, accounting for 17.81% of revenue, which is an increase of 6.08% year-on-year [1] - The company's return on invested capital (ROIC) was 19.29% last year, indicating strong capital returns [1] Balance Sheet Highlights - Accounts receivable stood at 243 million yuan, which is 139.14% of the net profit, indicating a significant amount of receivables relative to profit [2] - The company reported a decrease in cash and cash equivalents to 266.8 million yuan, down 9.97% year-on-year [1] - Interest-bearing liabilities decreased by 25.93% to 27.08 million yuan [1] Earnings Per Share - Earnings per share (EPS) for the period was 0.28 yuan, reflecting a year-on-year increase of 3.7% [1] - The company’s operating cash flow per share improved to 0.16 yuan, a 29.06% increase compared to the previous year [1] - Analysts expect the company's performance for 2025 to reach 199 million yuan, with an average EPS forecast of 0.5 yuan [2]

Core Viewpoint - The company, Jiyuan Group, reported a year-on-year increase in both revenue and net profit for the first half of the year, indicating positive financial performance [1]. Financial Performance - The company's operating revenue for the first half of the year reached 563,031,986.01 yuan, representing a year-on-year increase of 15.65% [1]. - The net profit attributable to shareholders of the listed company was 97,708,269.78 yuan, which is a year-on-year increase of 3.99% [1].

Core Viewpoint - The company, Jiyuan Group, reported a revenue increase of 15.65% year-on-year for the first half of 2025, indicating strong growth in its business operations [1]. Financial Performance - The company's revenue for the first half of 2025 was 563 million yuan, with a net profit attributable to shareholders of 97.71 million yuan, reflecting a year-on-year growth of 3.99% [1]. - The basic earnings per share for the reporting period was 0.28 yuan, and the weighted average return on equity was 9.90% [2]. - The gross profit margin for the first half of 2025 was 43.69%, down 1.38 percentage points year-on-year, while the net profit margin was 17.44%, a decrease of 1.94 percentage points compared to the same period last year [3]. - In the second quarter of 2025, the gross profit margin was 43.82%, showing a year-on-year decline of 2.84 percentage points but a quarter-on-quarter increase of 0.29 percentage points [3]. - The net profit margin for the second quarter was 18.58%, down 2.70 percentage points year-on-year but up 2.43 percentage points from the previous quarter [3]. Expense Analysis - The company's total operating expenses for the first half of 2025 amounted to 125 million yuan, an increase of 20.68 million yuan compared to the same period last year, resulting in an expense ratio of 22.14%, up 0.78 percentage points year-on-year [3]. - Sales expenses increased by 37.30%, management expenses rose by 28.05%, and research and development expenses grew by 9.61%, while financial expenses decreased by 272.23% [3]. Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 13 [3]. Company Overview - Jiyuan Group, established on September 17, 2002, is located at 1089 North Qinzhou Road, Xuhui District, Shanghai. The company specializes in the research, innovation, and industrialization of dietary nutritional supplements [4]. - The main business revenue composition includes HMB (29.29%), tablets (22.53%), glucosamine (17.66%), chondroitin sulfate (9.06%), and other nutritional raw materials [4]. - The company is classified under the food and beverage industry, specifically in food processing and health products, and is part of several concept sectors including margin financing, newly listed stocks, and expected profit growth [4].

Group 1 - The company, Jiyuan Group (603262), announced that it will hold its first extraordinary general meeting of shareholders on September 23, 2025 [1] - The agenda for the meeting includes proposals to change the registered capital, abolish the supervisory board, and amend the company's articles of association [1] - Additional proposals will involve the formulation, revision, and abolition of corporate governance systems [1]

Group 1 - The company reported a total operating revenue of 563 million yuan for the first half of 2025, representing a year-on-year increase of 15.65% [1] - The net profit attributable to shareholders of the parent company was 97.71 million yuan, showing a year-on-year growth of 3.99% [1] - The basic earnings per share were 0.28 yuan [1]

第一条 为进一步完善公司法人治理结构、维护中小股东利益，规范公司选 举董事行为，根据《中华人民共和国公司法》（下称"《公司法》"）、《上市公司治 理准则》《关于加强社会公众股股东权益保护的若干规定》及《技源集团股份有 限公司章程》（下称"《公司章程》"）、《技源集团股份有限公司股东会议事规则》 的有关规定，特制定本实施细则。 第二条 本实施细则所称累积投票制是指股东会在选举两名以上董事时采用 的一种投票方式。即股东会选举董事时，股东所持的每一股份拥有与该次股东会 应选举董事人数相等的投票权，股东拥有的投票权等于该股东持有股份数与应选 董事人数的乘积。股东既可以用所有投票权集中投票选举一位候选董事，也可以 分散投票给数位候选董事。 第三条 股东会选举产生的董事组成人数和构成应符合《公司法》《公司章程》 的规定。 第四条 本实施细则所称"董事"包括独立董事和非独立董事。由职工代表 担任的董事由公司职工代表大会选举产生或更换，不适用本实施细则的相关规 定。 技源集团股份有限公司 累积投票制度实施细则 技源集团股份有限公司 累积投票制度实施细则 （2025 年 8 月修订） 第一章 总 则 第二章 董事候选人的提名 ...

技源集团股份有限公司 关联交易管理制度 技源集团股份有限公司关联交易管理制度 （2025 年 8 月修订） 第一章 总则 第一条 为规范技源集团股份有限公司（以下简称"公司"）关联交易行为， 保护全体股东的合法权益，根据《中华人民共和国公司法》《中华人民共和国证 券法》《上海证券交易所股票上市规则》（简称"股票上市规则"）《上海证券交易 所上市公司自律监管指引第 5 号——交易与关联交易指引》《技源集团股份有限 公司章程》（以下简称"《公司章程》"）及相关规定，制定本制度。 第二条 公司关联交易应当定价公允、决策程序合规、信息披露规范，确保 关联交易行为不损害公司和全体股东尤其是中小股东的利益。 第三条 董事会下设的审计委员会履行公司关联交易控制和日常管理的职责。 董事会办公室负责定期更新和确认公司关联人名单，保管关联交易决策记录和决 议等文件，财务部负责建立和更新关联交易台账并及时沟通预警，共同配合协助 审计委员会切实履行公司关联交易控制和日常管理的职责。 第二章 关联人与关联交易 第四条 公司的关联人包括关联法人和关联自然人。 （三）由第六条所列公司的关联自然人直接或者间接控制的，或者由关联自 然人担任董 ...

技源集团股份有限公司 股东会网络投票实施细则 技源集团股份有限公司 股东会网络投票实施细则 第一章 总 则 第一条 为规范技源集团股份有限公司（以下简称"公司"）股东会网络投 票行为，便于公司股东行使表决权，保护投资者合法权益，根据《公司法》、《上 海证券交易所股票上市规则》、《上海证券交易所上市公司自律监管指引第 1 号 ——规范运作》等法律、法规和规范性文件以及《公司章程》《公司股东会议事 规则》的有关规定，制定本细则。 第二条 本细则所称股东会网络投票是指公司股东通过上海证券交易所（以 下简称"交易所"）上市公司股东会网络投票系统或其认可的其他股东会网络投 票系统行使表决权的行为。 第三条 公司召开股东会，应当按照相关规定向股东提供网络投票方式，履 行股东会相关的通知和公告义务，做好股东会网络投票的相关组织和准备工作。 第四条 公司为股东提供网络投票方式的，应当按照交易所相关临时公告格 式指引的要求，使用交易所公告编制软件编制股东会相关公告，并按规定披露。 第五条 股东会股权登记日登记在册且有权出席会议行使表决权的股东，均 可以按照本细则规定，通过交易所网络投票系统行使表决权。 第六条 公司利用上海证券 ...